Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM-1 in blood

Kidney International

Volumn 58, Issue 6, 2000, Pages 2533-2542

  Kas Deelen, A M ^a   Harmsen, M C ^a   De Maar, E F ^a   Oost Kort, W W ^a   Tervaert, J W C ^a   Van der Meer, J ^a   Van Son, W J ^a   The, T H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

E selectin; Endothelial cells; Kidney rejection; Soluble ICAM; Transplantation; Vascular cell adhesion molecule

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; CELL KINETICS; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; FEMALE; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0033667405     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00438.x     Document Type: Article

References (46)

1. Relationship between monitoring the viral load in blood, human cytomegalovirus pathophysiology and management strategies of patients after transplantation
2. CMV infection and allograft rejection
3. Role of cytomegalovirus infection in transplant arteriosclerosis
4. Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection
5. Circulating endothelial giant cells permissive for human cytomegalovirus (CMV) are detected in disseminated CMV infections with organ involvement
6. Circulating cytomegalovirus (CMV)-infected endothelial cells in marrow transplant patients with CMV disease and CMV infection
7. Uninfected and cytomegalic endothelial cells in blood during cytomegalovirus infection: Effect of acute rejection
8. Annotation: A reliable marker of endothelial dysfunction: Does it exist?
9. Increased factor VIII as an index of vascular injury in cyclosporine nephrotoxicity
10. The coagulolytic system and endothelial function in cyclosporine-treated kidney allograft recipients
11. Hepatic endothelial cells: Targets in liver allograft rejection?
12. Elevated factor VIII as a marker for vascular type of rejection after renal transplantation
13. Assays for measuring soluble cellular adhesion molecules and soluble cytokine receptors
14. Circulating ICAM-1: Novel parameter of renal graft rejection
15. The association of increased soluble VCAM-1 levels with CMV disease in human kidney allograft recipients
16. Lack of correlation of soluble E-selectin level with renal transplant rejection
17. Value of circulating immune parameters in renal transplantation
18. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
19. Quantitative measurement of cytomegalovirus-specific IgG and IgM antibodies in relation to cytomegalovirus antigenaemia and disease activity in kidney recipients with an active cytomegalovirus infection
20. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection
21. Cytomegalovirus-antigenemia as a useful marker of symptomatic cytomegalovirus disease after renal transplantation: A report of 130 consecutive patients
22. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon
23. Leukocyte endothelial adhesion molecules
24. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
25. The association of the induction of vascular cell adhesion molecule-1 with cytomegalovirus antigenemia in human heart allografts
26. Expression of adhesion molecules and their ligands in liver allografts during cytomegalovirus (CMV) infection and acute rejection
27. ICAM-1 and VCAM-1 in human renal allograft rejection
28. Distribution of cell adhesion molecules (ICAM-1, VCAM-1, ELAM-1) in renal tissue during allograft rejection
29. The release of cytokines, adhesion molecules, and extracellular matrix parameters during and after reperfusion in human liver transplantation
30. A pilot study of soluble adhesion molecules as surrogate markers for acute liver allograft rejection
31. Serum soluble adhesion molecules and cytokines in cardiac allograft rejection: The Manchester Transplant Cytokine Group
32. Soluble e-selectin, ICAM-1, and VCAM-1 levels in renal allograft recipients
33. Adhesion molecules and rejection of renal allografts
34. Risk factors for chronic rejection in renal allograft recipients
35. Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft
36. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation
37. Cytomegalovirus infection and donor/recipient HLA antigens: Interdependent cofactors in pathogenesis of vanishing bile-duct syndrome after liver transplantation
38. Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells
39. Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells
40. CMV as an exacerbating agent in transplant vascular sclerosis: Potential immune-mediated mechanisms modelled in vitro
41. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat. I. Viral induction expression of endothelial cell adhesion molecules
42. Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression
43. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall: A possible linkage with enhanced allograft arteriosclerosis
44. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts
45. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis
46. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart